We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$1.14T
AUM Growth
+$58.2B
Cap. Flow
+$25.9B
Cap. Flow %
2.28%
Top 10 Hldgs %
30.92%
Holding
4,723
New
114
Increased
3,571
Reduced
603
Closed
134

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.76B
2
XOM icon
ExxonMobil
XOM
+$1.36B
3
AAPL icon
Apple
AAPL
+$1.05B
4
AMZN icon
Amazon
AMZN
+$1.02B
5
NVDA icon
NVIDIA
NVDA
+$972M

Sector Composition

Rank Sector Weight
1 Technology 31.88%
2 Financials 12.28%
3 Healthcare 11.67%
4 Consumer Discretionary 10.22%
5 Communication Services 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLIS
4076
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$123K ﹤0.01%
14,020
+2,130
+18% +$18.9K
AIFC
4077
AI Financial Corp
AIFC
$61.3M
$123K ﹤0.01%
55,053
+40,436
+277% +$129K
MBOT icon
4078
Microbot Medical
MBOT
$127M
$122K ﹤0.01%
119,937
+27,533
+30% +$28.3K
CASI
4079
DELISTED
CASI Pharmaceuticals
CASI
$122K ﹤0.01%
22,221
TLF icon
4080
Tandy Leather Factory
TLF
$20M
$122K ﹤0.01%
27,152
-952
-3% -$4.41K
TVRD
4081
Tvardi Therapeutics
TVRD
$23.4M
$122K ﹤0.01%
13,130
-15,248
-54% -$364K
INLX icon
4082
Intellinetics
INLX
$24.2M
$121K ﹤0.01%
18,859
+436
+2% +$3.05K
ONYX
4083
DELISTED
Onyx Acquisition Co. I Class A Ordinary Shares
ONYX
$120K ﹤0.01%
10,724
DFLI icon
4084
Dragonfly Energy
DFLI
$18.9M
$119K ﹤0.01%
1,567
-3,243
-67% -$251K
PLAO
4085
DELISTED
Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares
PLAO
$119K ﹤0.01%
+10,415
New +$118K
PROF
4086
Profound Medical
PROF
$269M
$119K ﹤0.01%
14,049
MDAI icon
4087
Spectral AI
MDAI
$55.7M
$118K ﹤0.01%
67,211
+8,195
+14% +$14.7K
GBNY
4088
DELISTED
Generations Bancorp NY, Inc. Common Stock
GBNY
$118K ﹤0.01%
11,268
-544
-5% -$5.57K
VBIV
4089
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$118K ﹤0.01%
178,822
+35,201
+25% +$21.9K
AXIL
4090
AXIL Brands
AXIL
$40M
$118K ﹤0.01%
+15,499
New +$164K
BATL icon
4091
Battalion Oil
BATL
$28.8M
$118K ﹤0.01%
35,256
LUMO
4092
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$118K ﹤0.01%
50,727
+3,131
+7% +$8.09K
AMPG icon
4093
AmpliTech
AMPG
$147M
$117K ﹤0.01%
111,367
-1,936
-2% -$3.44K
GTAC
4094
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
$117K ﹤0.01%
10,407
NVOS
4095
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
$117K ﹤0.01%
155,452
+27,523
+22% +$17.6K
ADAP
4096
DELISTED
Adaptimmune Therapeutics
ADAP
$115K ﹤0.01%
117,909
TCRT icon
4097
Alaunos Therapeutics
TCRT
$4.86M
$114K ﹤0.01%
16,359
+1,317
+9% +$15.7K
FLZH
4098
Flash Sports & Media Holdings
FLZH
$73.3M
$114K ﹤0.01%
3,438
+306
+10% +$12.2K
IGTA
4099
DELISTED
Inception Growth Acquisition Limited Common Stock
IGTA
$114K ﹤0.01%
10,120
CBRG
4100
DELISTED
Chain Bridge I Class A Ordinary Shares
CBRG
$114K ﹤0.01%
10,302

Similar funds

Geode Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Geode Capital Management held 4,723 positions worth $1.14T, up 5.4% from $1.08T the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Geode Capital Management's Q2 2024 filing shows 114 new, 3,571 increased, 603 reduced and 134 closed positions. Its largest new stake was GE Vernova: 5,513,744 shares worth $943M. The largest sale was Pioneer Natural Resource Co., an estimated $1.24B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2024 buy was GE Vernova: 5,513,744 shares worth $943M.
  • Geode Capital Management added most to Microsoft in Q2 2024, an estimated $1.76B increase.
  • Geode Capital Management's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $718M.
  • Geode Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.24B.
  • Geode Capital Management's ten largest holdings make up 31% of its $1.14T portfolio in Q2 2024.
  • Geode Capital Management opened 114 new positions and closed 134 in Q2 2024.
  • Geode Capital Management's portfolio value rose 5.4% quarter-over-quarter to $1.14T.

Based on Geode Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.